Menu

Question 741

Topic: Biology, Genetics & Bone Healing

A 32-year-old female presents with wrist pain. Radiographs demonstrate an expansile, eccentrically located lytic lesion in the distal radius epiphysis without a sclerotic rim. Biopsy confirms a giant cell tumor of bone.

Because the tumor involves the joint extensively, neoadjuvant medical therapy is planned to facilitate joint-sparing surgery. The primary medical treatment (denosumab) for this condition targets which of the following?

. Receptor activator of nuclear factor-kappa B (RANK) receptor
. Receptor activator of nuclear factor-kappa B ligand (RANKL)
. Osteoprotegerin (OPG)
. Macrophage colony-stimulating factor (M-CSF)
. Vascular endothelial growth factor (VEGF)

Correct Answer & Explanation

. Receptor activator of nuclear factor-kappa B ligand (RANKL)


Explanation

Giant cell tumor of bone is characterized by neoplastic mononuclear stromal cells that express RANKL, which subsequently recruits and activates normal osteoclast-like giant cells that express RANK, leading to bone resorption. Denosumab is a human monoclonal antibody that binds directly to RANKL (not the RANK receptor itself), preventing its interaction with RANK. This inhibits osteoclast-like giant cell formation and survival, leading to tumor consolidation and intralesional ossification.

Question 742

Topic: Biology, Genetics & Bone Healing

A 32-year-old female presents with knee pain. Radiographs show a large, eccentric, purely lytic, expansile lesion in the distal femoral epiphysis extending to the subchondral bone. A biopsy reveals numerous multinucleated giant cells in a stroma of mononuclear cells. For advanced, unresectable cases, or as a neoadjuvant therapy to facilitate intralesional curettage, which of the following monoclonal antibodies is an FDA-approved targeted treatment?

. Bevacizumab
. Infliximab
. Denosumab
. Rituximab
. Zoledronic acid

Correct Answer & Explanation

. Denosumab


Explanation

The lesion described is a Giant Cell Tumor (GCT) of bone. The neoplastic cells in GCT are actually the spindle-shaped mononuclear stromal cells, which highly express RANKL. This stimulates the recruitment and differentiation of osteoclast-like multinucleated giant cells that cause the aggressive bone lysis. Denosumab is a monoclonal antibody against RANKL, effectively inhibiting this pathway, leading to tumor consolidation and ossification. Zoledronic acid is a bisphosphonate, not a monoclonal antibody.

Question 743

Topic: Biology, Genetics & Bone Healing
Bone Morphogenetic Proteins (BMPs) are members of the TGF-beta superfamily and play a critical role in osteoinduction. Which two specific BMPs have been commercially produced using recombinant DNA technology and approved by the FDA for specific orthopedic applications, such as anterior lumbar interbody fusions and open tibial shaft fractures?
. BMP-1 and BMP-2
. BMP-3 and BMP-4
. BMP-2 and BMP-7
. BMP-4 and BMP-7
. BMP-6 and BMP-9

Correct Answer & Explanation

. BMP-2 and BMP-7


Explanation

BMP-2 (rhBMP-2, commercial name INFUSE) is FDA-approved for anterior lumbar interbody fusion (ALIF) and open tibial shaft fractures. BMP-7 (rhBMP-7, also known as Osteogenic Protein-1 or OP-1) was FDA-approved under a Humanitarian Device Exemption for recalcitrant long bone nonunions and revision posterolateral lumbar fusions. BMP-3 actually has an inhibitory effect on bone formation.

Question 744

Topic: Biology, Genetics & Bone Healing

A 35-year-old woman undergoes open reduction and internal fixation of a diaphyseal radial fracture using a dynamically compressed plate, achieving absolute fracture stability and anatomical reduction. Which of the following best describes the primary mechanism of bone healing expected in this specific environment?

. Endochondral ossification with massive cartilaginous callus formation
. Intramembranous ossification with robust periosteal bridging callus
. Cutting cone remodeling by osteoclasts followed directly by osteoblastic bone deposition
. Formation of woven bone directly from mesenchymal stem cells without any remodeling
. Chondrocyte hypertrophy followed by vascular invasion and subsequent osteoid deposition

Correct Answer & Explanation

. Cutting cone remodeling by osteoclasts followed directly by osteoblastic bone deposition


Explanation

Absolute stability achieved through dynamic compression plating results in primary (direct) bone healing. This process bypasses callus formation. It occurs via Haversian remodeling, where 'cutting cones' of osteoclasts cross the fracture line, followed immediately by osteoblasts laying down lamellar bone. Secondary bone healing (callus formation) occurs in settings of relative stability.

Question 745

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman complains of left knee pain. Radiographs show an eccentric, purely lytic lesion in the distal femoral epiphysis extending to the subchondral bone, without a sclerotic margin. Biopsy reveals multinucleated giant cells interspersed among mononuclear stromal cells. For recurrent or surgically unsalvageable cases of this specific tumor, which of the following is the most appropriate targeted medical therapy?

. Imatinib
. Denosumab
. Methotrexate
. Doxorubicin
. Rituximab

Correct Answer & Explanation

. Denosumab


Explanation

This is a Giant Cell Tumor (GCT) of bone. The neoplastic cells in GCT are actually the mononuclear stromal cells, which heavily express RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand). This expression recruits and activates normal osteoclasts (the giant cells), causing massive osteolysis. Denosumab, a monoclonal antibody against RANKL, is the medical treatment of choice for unresectable or highly recurrent GCTs.

Question 746

Topic: Biology, Genetics & Bone Healing

Distraction osteogenesis, as pioneered by Ilizarov, is a powerful technique for limb lengthening and deformity correction. The formation of new bone across the distraction gap primarily relies on which biological process?

. Endochondral ossification
. Intramembranous ossification
. Appositional ossification
. Creeping substitution
. Chondrolysis

Correct Answer & Explanation

. Intramembranous ossification


Explanation

Distraction osteogenesis relies primarily on intramembranous ossification. Under conditions of stable fixation and controlled, gradual distraction (typically 1 mm per day), osteoblasts directly deposit osteoid along the collagen bundles in the distraction gap without a cartilaginous intermediate. Endochondral ossification (bone formation via a cartilage model) is typical of secondary fracture healing with relative stability.

Question 747

Topic: Biology, Genetics & Bone Healing

Which of the following Bone Morphogenetic Proteins (BMPs) is an FDA-approved osteoinductive agent for the treatment of acute, open tibial shaft fractures?

. BMP-2
. BMP-4
. BMP-7
. BMP-9
. BMP-14

Correct Answer & Explanation

. BMP-2


Explanation

Recombinant human BMP-2 (rhBMP-2) is FDA approved for acute open tibial shaft fractures treated with an intramedullary nail, as well as for anterior lumbar interbody fusion (ALIF). BMPs belong to the TGF-beta superfamily and exert their osteoinductive effects via the Smad 1/5/8 signaling pathways.

Question 748

Topic: Biology, Genetics & Bone Healing

A 35-year-old female presents with knee pain. Radiographs reveal an eccentric, lytic epiphyseal lesion extending to the subchondral bone of the distal femur. Biopsy confirms a Giant Cell Tumor (GCT) of bone.

Which cellular component of this tumor expresses RANKL, serving as the target for medical therapy?

. Osteoclast-like multinucleated giant cells
. Neoplastic mononuclear stromal cells
. Reactive osteoblasts
. Endothelial cells
. Chondroid matrix cells

Correct Answer & Explanation

. Neoplastic mononuclear stromal cells


Explanation

In Giant Cell Tumor of bone, the neoplastic cells are the mononuclear spindle-like stromal cells. These cells express high levels of RANKL. The multinucleated giant cells are reactive osteoclast-like cells that express RANK. Denosumab, a monoclonal antibody against RANKL, targets the neoplastic mononuclear cells' product to prevent the recruitment of the destructive giant cells.

Question 749

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory of bone healing, the process of primary bone healing (direct remodeling by osteonal cutting cones without callus formation) depends heavily on the mechanical environment. For primary bone healing to occur, the interfragmentary strain must remain below which of the following thresholds?

. 2%
. 10%
. 15%
. 20%
. 30%

Correct Answer & Explanation

. 2%


Explanation

Perren's strain theory postulates that different tissues can tolerate different amounts of deformation (strain) before failure. Granulation tissue tolerates up to 100% strain, cartilage tolerates up to 10%, and bone tolerates only up to 2%. For primary (direct) bone healing to occur, there must be absolute stability with interfragmentary strain less than 2%. Secondary bone healing (callus formation) occurs when strain is between 2% and 10%.

Question 750

Topic: Biology, Genetics & Bone Healing

A 30-year-old female presents with a painful lytic epiphyseal lesion of the distal femur. Biopsy confirms the diagnosis of Giant Cell Tumor of bone. Due to the proximity to the joint space and the large size of the defect, the multidisciplinary tumor board recommends neoadjuvant treatment with Denosumab to downstage the tumor prior to intralesional curettage. What is the precise mechanism of action of Denosumab?

. Inhibition of osteoclast proton pumps
. Monoclonal antibody against RANK Ligand
. Monoclonal antibody against the RANK receptor
. Inhibition of vascular endothelial growth factor (VEGF)
. Cross-linking of intracellular DNA

Correct Answer & Explanation

. Monoclonal antibody against RANK Ligand


Explanation

Giant cell tumor of bone (GCTB) is characterized by neoplastic mononuclear stromal cells that express RANKL, which recruits and activates the multinucleated giant cells (osteoclasts) responsible for the osteolysis. Denosumab is a fully human monoclonal antibody that binds directly to RANK Ligand (RANKL), preventing it from interacting with the RANK receptor on osteoclasts and their precursors, thereby inhibiting osteoclast-mediated bone destruction.

Question 751

Topic: Biology, Genetics & Bone Healing

Which Bone Morphogenetic Protein (BMP) is most closely associated with the FDA-approved indication for use in acute, open tibial shaft fractures?

. BMP-2
. BMP-3
. BMP-4
. BMP-7
. BMP-9

Correct Answer & Explanation

. BMP-2


Explanation

Recombinant human BMP-2 (rhBMP-2) is FDA approved for the treatment of acute open tibial shaft fractures, typically administered via an absorbable collagen sponge. rhBMP-7 (also known as Osteogenic Protein-1 or OP-1) was previously approved under a humanitarian device exemption for recalcitrant tibial nonunions.

Question 752

Topic: Biology, Genetics & Bone Healing

A 30-year-old female presents with knee pain. Radiographs show an eccentric, lytic epiphyseal lesion of the proximal tibia.

Biopsy reveals multinucleated giant cells in a background of mononuclear stromal cells. What is the primary molecular target of the systemic therapy commonly used to treat unresectable cases of this tumor?

. Vascular Endothelial Growth Factor (VEGF)
. Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)
. Platelet-Derived Growth Factor (PDGF)
. Mammalian Target of Rapamycin (mTOR)
. Human Epidermal Growth Factor Receptor 2 (HER2)

Correct Answer & Explanation

. Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)


Explanation

The diagnosis is Giant Cell Tumor of Bone (GCTB). The neoplastic cells are the mononuclear stromal cells, which express high levels of RANKL. This recruits and activates osteoclast-like giant cells. Denosumab, a monoclonal antibody against RANKL, is used for unresectable GCTB or to downstage tumors prior to surgery.

Question 753

Topic: Biology, Genetics & Bone Healing

An adult tibia shaft fracture is treated with a statically locked intramedullary nail, creating a biomechanical environment that allows for micromotion at the fracture site. This environment promotes secondary bone healing. What is the correct physiological sequence of secondary bone healing?

. Inflammation, soft callus, hard callus, remodeling
. Soft callus, hard callus, inflammation, remodeling
. Inflammation, hard callus, soft callus, remodeling
. Inflammation, remodeling, soft callus, hard callus
. Hard callus, soft callus, remodeling, inflammation

Correct Answer & Explanation

. Inflammation, soft callus, hard callus, remodeling


Explanation

Secondary bone healing occurs when there is relative stability (micromotion) at the fracture site, promoting callus formation. The classic sequential phases are: 1) Inflammation (hematoma formation and cytokine release), 2) Soft callus (fibrocartilage generation via chondrogenesis), 3) Hard callus (conversion of cartilage to woven bone via endochondral ossification), and 4) Remodeling (replacement of woven bone with lamellar bone via osteoclast and osteoblast activity).

Question 754

Topic: Biology, Genetics & Bone Healing

A 65-year-old male complains of severe mechanical back pain and profound fatigue. Laboratory tests show anemia, hypercalcemia, and an elevated M-spike on serum protein electrophoresis. Plain radiographs demonstrate multiple 'punched-out' lytic lesions in the skull and spine. What is the current imaging modality of choice to accurately assess the extent of skeletal burden in this disease?

. Technetium-99m bone scintigraphy
. Whole-body low-dose CT or MRI
. Gallium-67 scan
. Dual-energy x-ray absorptiometry (DEXA)
. Positron emission tomography without CT

Correct Answer & Explanation

. Whole-body low-dose CT or MRI


Explanation

The diagnosis is Multiple Myeloma. The characteristic bone lesions are purely osteolytic, caused by myeloma cells stimulating osteoclasts (via RANKL) while inhibiting osteoblast activity (via DKK1 and sFRP-2). Because there is little to no reactive osteoblastic bone formation, traditional Technetium-99m bone scans frequently yield false negatives. Therefore, whole-body low-dose CT, whole-body MRI, or PET-CT are the modalities of choice to identify myeloma bone lesions.

Question 755

Topic: Biology, Genetics & Bone Healing

Parathyroid hormone (PTH) plays a central role in maintaining systemic calcium homeostasis by acting on bone, kidneys, and the intestines. What is the direct mechanism by which continuously elevated PTH levels stimulate bone resorption?

. Directly binding to receptors on mature osteoclasts to increase their resorptive activity
. Binding to receptors on osteoblasts, causing upregulation of RANKL, which subsequently activates osteoclasts
. Downregulating the expression of RANKL and upregulating osteoprotegerin (OPG)
. Stimulating the release of calcitonin from the thyroid gland
. Inducing rapid apoptosis of osteoblasts

Correct Answer & Explanation

. Binding to receptors on osteoblasts, causing upregulation of RANKL, which subsequently activates osteoclasts


Explanation

Osteoclasts do not possess receptors for PTH. Instead, continuous PTH binds to PTH receptors (PTH1R) on the surface of osteoblasts. This binding stimulates osteoblasts to upregulate the expression of RANKL (and downregulate OPG). RANKL then binds to the RANK receptor on osteoclast precursors, promoting their differentiation, fusion, and activation into mature bone-resorbing osteoclasts.

Question 756

Topic: Biology, Genetics & Bone Healing

Bone Morphogenetic Proteins (BMPs) are used as osteoinductive agents in spine fusions and nonunion surgery. Which of the following BMPs is an FDA-approved recombinant protein utilized in anterior lumbar interbody fusion (ALIF) within a specific carrier?

. rhBMP-2
. rhBMP-3
. rhBMP-4
. rhBMP-6
. rhBMP-9

Correct Answer & Explanation

. rhBMP-2


Explanation

rhBMP-2 (recombinant human bone morphogenetic protein-2) is FDA approved for use in single-level anterior lumbar interbody fusions (ALIF) with an absorbable collagen sponge carrier and a specific interbody cage. It acts as an osteoinductive agent by stimulating mesenchymal stem cells to differentiate into osteoblasts.

Question 757

Topic: Biology, Genetics & Bone Healing

A 29-year-old female presents with knee pain. Radiographs show an eccentric, lytic lesion in the distal femoral epiphysis extending into the metaphysis.

Biopsy confirms a Giant Cell Tumor of bone. Neoadjuvant therapy with denosumab is considered. What is the mechanism of action of this medication?

. Monoclonal antibody against Vascular Endothelial Growth Factor (VEGF).
. Bisphosphonate that inhibits osteoclast farnesyl pyrophosphate synthase.
. Monoclonal antibody against Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL).
. Tyrosine kinase inhibitor targeting c-kit.
. Selective estrogen receptor modulator.

Correct Answer & Explanation

. Monoclonal antibody against Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL).


Explanation

Denosumab is a human monoclonal antibody that binds to RANKL. In Giant Cell Tumor of Bone (GCTB), neoplastic mononuclear stromal cells secrete massive amounts of RANKL, recruiting and activating the reactive osteoclast-like multinucleated giant cells that cause bone destruction. Denosumab blocks this interaction, inhibiting osteoclast activity.

Question 758

Topic: Biology, Genetics & Bone Healing

Which phase of fracture healing is most dependent on the inflammatory cascade initiated by macrophages and platelets?

. Hard callus formation
. Soft callus formation
. Hematoma formation and inflammation
. Remodeling
. Woven bone deposition

Correct Answer & Explanation

. Hematoma formation and inflammation


Explanation

The initial phase of fracture healing is the hematoma formation and inflammatory phase. Platelets and macrophages release cytokines (e.g., PDGF, TGF-beta) that recruit mesenchymal stem cells and initiate the healing process.

Question 759

Topic: Biology, Genetics & Bone Healing

A 32-year-old female is diagnosed with a Giant Cell Tumor (GCT) of the proximal tibia. She is prescribed Denosumab as neoadjuvant therapy.

What is the precise mechanism of action of Denosumab in treating GCT?

. Binds to RANK receptor on osteoclasts, directly inhibiting their activation
. Binds to RANK Ligand (RANKL) expressed by the mononuclear stromal cells
. Inhibits vascular endothelial growth factor (VEGF), leading to tumor necrosis
. Binds directly to the multinucleated giant cells and induces apoptosis
. Inhibits farnesyl pyrophosphate synthase within osteoclasts

Correct Answer & Explanation

. Binds to RANK Ligand (RANKL) expressed by the mononuclear stromal cells


Explanation

In Giant Cell Tumor of bone, the neoplastic cells are actually the mononuclear stromal cells, not the giant cells themselves. These stromal cells overexpress RANK Ligand (RANKL), which recruits and activates the reactive osteoclast-like multinucleated giant cells that cause bone destruction. Denosumab is a monoclonal antibody that binds to RANKL, preventing it from interacting with the RANK receptor on osteoclast precursors, thereby halting osteolysis.

Question 760

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a critical role in osteoinduction and fracture healing.

Upon BMP binding to its serine/threonine kinase cell surface receptors, which downstream intracellular signaling molecules are directly phosphorylated to translocate to the nucleus?

. JAK/STAT
. Smad 1, 5, and 8
. Smad 2 and 3
. Wnt/beta-catenin
. NF-kappaB

Correct Answer & Explanation

. Smad 1, 5, and 8


Explanation

BMPs signal through serine/threonine kinase receptors. Upon binding, the receptors phosphorylate specific receptor-regulated Smad proteins. For BMPs, the specific intracellular mediators are Smad 1, Smad 5, and Smad 8. In contrast, TGF-beta primarily utilizes Smad 2 and Smad 3. The phosphorylated Smads then form a complex with Smad 4 to translocate into the nucleus and regulate gene expression.